Glucagon-like peptide-2 analogs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8846625
SERIAL NO

13794314

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
1149336 ONTARIO INCTORONTO ONTARIO M6B 3G3

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crivici, Anna E Laguna Niguel, US 9 258
Drucker, Daniel J Toronto, CA 38 896
Sumner-Smith, Martin Palgrave, CA 20 645

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00